$6.97-0.00 (-0.05%)
The Joint Corp.
The Joint Corp. in the Healthcare sector is trading at $6.97 with a market capitalization of $118M. Wall Street consensus targets $10.00 (3 analysts), implying a +43.4% move over the next 12 months. The stock is currently near its 52-week low of $6.80, remaining 20.0% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. Risk note: RSI 11 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $15.18Mβ | $14.82Mβ | $15.17Mβ | $13.38Mβ | $13.27M |
| Gross Profit | $12.70Mβ | $12.10Mβ | $12.35Mβ | $10.72Mβ | $10.50M |
| Operating Income | -$160,564β | $898,995β | $743,895β | $160,915β | -$1.13M |
| Net Income | $653,021β | $1.30Mβ | $991,097β | $855,009β | $93,363 |
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor mana...